Fintel reports that on June 26, 2025, Citigroup upgraded their outlook for Truist Financial (NYSE:TFC) from Neutral to Buy.

In a report released yesterday, David S Macdonald from Truist Financial maintained a Buy rating on Option Care Health (OPCH – Research Report), with a price target of $34.00. The company’s ...

Truist Financial Corp. may consider selling the remaining 80% stake in its profitable insurance subsidiary to a private-equity group for a potential $10 billion. Truist completed on April 3 ...

Evolent Health (NYSE:EVH – Get Free Report) had its target price decreased by research analysts at Truist Financial from $15.00 to $14.00 in a report issued on Thursday,Benzinga reports.

Truist Financial Corporation (NYSE: TFC) today announced that Chief Financial Officer Mike Maguire will speak at the UBS Financial Services Conference on Tuesday, Feb. 11, 2025, at 1:00 p.m. ET.

The recent sale of Truist Insurance Holdings (TIH) should boost financial health and allow for improved efficiency. Rate cuts should positively impact Truist's stock price, which is currently ...

Truist is the sixth-largest U.S. insurance brokerage. The bank said July 19 in its second-quarter earnings report that its insurance revenue was the top revenue producer at $825 million, up 13.5% ...

When BB&T and SunTrust merged at the end of 2019, it created a top 10 U.S. bank called Truist Financial (TFC 2.65%) that many analysts thought had considerable commercial real estate (CRE) exposure.

Truist Financial will sell its remaining stake in Truist Insurance Holdings, valued at $15.5 billion, to a group of private-equity firms, the bank announced Tuesday.